Economic impact of oral ciprofloxacin following standard intravenous therapy

Diagn Microbiol Infect Dis. 1990 Mar-Apr;13(2):187-9. doi: 10.1016/0732-8893(90)90107-7.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Ciprofloxacin / administration & dosage
  • Ciprofloxacin / therapeutic use*
  • Costs and Cost Analysis
  • Female
  • Humans
  • Injections, Intravenous
  • Length of Stay / economics
  • Male
  • Middle Aged
  • Random Allocation
  • Respiratory Tract Infections / drug therapy*

Substances

  • Ciprofloxacin